Graeme Clark Collection
Permanent URI for this collection
Search Results
1 - 3 of 3
-
ItemAuditory processing abilities in children using cochlear implants: their relevance to speech perception [Abstract]( 1999)This study aimed to investigate the relationships between some basic auditory processing skills, subject variables and speech perception ability in young children using cochlear implants. A modification of the play audiometry procedure was used to measure electrode discrimination and "rate-of-processing" ability in seventeen 4-10 year old children. In the electrode discrimination task, children responded with a game-like motor response when a repeating stimulation on a reference electrode "changed" to a different electrode. In the "rate-of processing" task, children had to respond to the "change" to a different electrode, when the duration of the stimuli and the time interval between the stimuli were decreased. Normally hearing children were assessed on this task with acoustic stimulation. Nonverbal intelligence, speech feature discrimination and closed-set word recognition were also measured in the children using implants.
-
ItemMultichannel cochlear implants in children: an overview of experimental and clinical results at the University of Melbourne [Opening Lecture]( 1992)During the last decade there has been great progress in the clinical management of profound, postlinguistically deafened adults through the use of multichannel cochlear implants. The device developed by The University of Melbourne in association with Cochlear Pty Ltd, electrically stimulates selective regions of the auditory nerve using an array of 22 platinum (Pt) electrodes located in the scala tympani. Its development followed basic experimental studies and the development and evaluation of a prototype device in the 1970's. Following safety studies and a successful clinical trial, the Melbourne/Cochlear multichannel implant was approved for use in adults by the United States Food and Drug Administration (FDA) in 1985. More than 3000 patients throughout the world have since been implanted with this device, many being able to understand a significant amount of unfamiliar, connected speech without lipreading Following miniaturization of the implant, it became suitable for use with children. In 1990, after additional biological safety and clinical investigations, the FDA approved the use of the Melbourne/Cochlear multichannel implant for profoundly deaf children above the age of two years. And in 1991, the device received the medical device implantation approval certificate from the Japanese Government. The present paper presents an overview of our recent biological safety studies and clinical experience in children, and discusses the likely future development of these devices.
-
ItemFuture developments in speech processing for multichannel cochlear implants in children [Abstract]( 1992)The average speech perception score for adult implant patients is now about 60% on an open-set sentence test without lipreading. This is higher than the scores obtained by many profound and severe-to-profoundly impaired hearing aid users. This suggests that some hearing aid users, particularly those who use a hearing aid in one ear only, could benefit from a cochlear implant. As neither the implant nor the hearing aid will provide perfect speech recognition it is to be expected that this group should obtain maximum benefit by using the hearing aid in one ear together with the implant in the other ear. However, experience with this group of patients has shown that many people find the use of two independent devices unacceptable. Furthermore, perceptual interaction of the acoustic and electrical signals makes it desirable to be able to control the two outputs in a more co-ordinated way than is possible with two independent devices. Consequently, a "bimodal" speech processor has been developed with both acoustic and electrical outputs controlled from the same speech processing unit. Feature coding aspects of the implant processing have been applied to the acoustic signal in such a way as to enhance speech perception with the hearing aid and improve compatibility with the implant. Initial testing with the bimodal aid shows promise to help severely-to-profoundly impaired individuals. The device has also been useful as a research tool to investigate the complex interactions of simultaneous acoustic and electrical stimulation. The Spectral Maxima Sound Processor (SMSP) has also been developed at the University of Melbourne for use with the Nucleus cochlear implant. Studies with adult subjects have shown improved perception of vowels, consonants, words and sentences in quiet and sentences in background noise with the SMSP as compared with the MSP(MULTIPEAK) which is currently supplied for use with this implant. Results for four subjects showed mean scores for open set sentences at a 10 dB signal-to-noise ratio of 78.7% for the SMSP and 50.0% for the MSP. Mean scores for the same group on open set monosyllabic words in quiet were 57.4% for SMSP and 39.9% for MSP. These results suggest that future improvements in speech perception will be possible for children using the Nucleus cochlear implant.